Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer

Cannabidiol, a major non-psychotomimetic compound derived from Cannabis sativa, is a potential therapeutic agent for a variety of diseases such as inflammatory diseases, chronic neurodegenerative diseases, and cancers. Here, we found that the combination of cannabidiol and TNF-related apoptosis-indu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Kim, Jung Lim, Kim, Bo Ram, Kim, Dae Yeong, Jeong, Yoon A., Jeong, Soyeon, Na, Yoo Jin, Park, Seong Hye, Yun, Hye Kyeong, Jo, Min Jee, Kim, Bu Gyeom, Kim, Han Do, Kim, Dae Hyun, Oh, Sang Cheul, Lee, Sun Il, Lee, Dae-Hee
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562873/
https://ncbi.nlm.nih.gov/pubmed/31075907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050642
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados